149 related articles for article (PubMed ID: 11750539)
21. Cytomegalovirus reactivation and preemptive therapy after liver transplant.
Davoudi S; Kasraianfard A; Ahmadinejad Z; Najafi A; Salimi J; Makarem J; Sohrabpour AA; Jafarian A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():72-5. PubMed ID: 24635797
[TBL] [Abstract][Full Text] [Related]
22. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus infection after liver transplantation incidence, risks, and benefits of prophylaxis.
Weigand K; Schnitzler P; Schmidt J; Chahoud F; Gotthardt D; Schemmer P; Stremmel W; Sauer P
Transplant Proc; 2010 Sep; 42(7):2634-41. PubMed ID: 20832559
[TBL] [Abstract][Full Text] [Related]
24. CMV in kidney transplantation: a single center experience over 22 years.
Nashan B; Lück R; Kliem V; Brunkhorst R; Schlitt HJ; Klempnauer J
Clin Transpl; 1999; ():181-8. PubMed ID: 11038636
[TBL] [Abstract][Full Text] [Related]
25. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
26. Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
Conti DJ; Isenberg A; Shen GK; Hahn A; Singh TP
Transplant Proc; 1998 Jun; 30(4):1314-5. PubMed ID: 9636533
[No Abstract] [Full Text] [Related]
27. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.
Singh N; Wannstedt C; Keyes L; Mayher D; Tickerhoof L; Akoad M; Wagener MM; Cacciarelli TV
Liver Transpl; 2008 Feb; 14(2):240-4. PubMed ID: 18236404
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus infection during heart transplantation: assessment of a therapeutic protocol without prophylaxis.
Decoene C; Pol A; Dewilde A; Wattre P; Prat A; Stankowiak C; Warembourg H
Transplant Proc; 1995 Aug; 27(4):2523. PubMed ID: 7652913
[No Abstract] [Full Text] [Related]
29. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
[No Abstract] [Full Text] [Related]
30. Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients.
Brennan DC; Garlock KA; Lippmann BJ; Buller RS; Gaudreault-Keener M; Lowell JA; Miller SB; Shenoy S; Howard TK; Storch GA
Transplant Proc; 1997; 29(1-2):809-11. PubMed ID: 9123536
[No Abstract] [Full Text] [Related]
31. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients.
Bonon SH; Menoni SM; Rossi CL; De Souza CA; Vigorito AC; Costa DB; Costa SC
J Infect; 2005 Feb; 50(2):130-7. PubMed ID: 15667914
[TBL] [Abstract][Full Text] [Related]
32. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
Singh N
Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
Ham JM; Shelden SL; Godkin RR; Posner MP; Fisher RA
Transplant Proc; 1995 Oct; 27(5 Suppl 1):31-3. PubMed ID: 7482814
[No Abstract] [Full Text] [Related]
34. Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation.
Sancho A; Górriz JL; Crespo JF; Avila A; Alcaraz MJ; García Ramos JL; Pallardó LM
Transplant Proc; 1999 Sep; 31(6):2337-8. PubMed ID: 10500606
[No Abstract] [Full Text] [Related]
35. Cytomegalovirus infection as a common complication following liver transplantation.
Oldakowska-Jedynak U; Niewczas M; Ziolkowski J; Mucha K; Foroncewicz B; Bartlomiejczyk I; Senatorski G; Wyzgal J; Krawczyk M; Zieniewicz K; Nyckowski P; Paczek L
Transplant Proc; 2003 Sep; 35(6):2295-7. PubMed ID: 14529920
[TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL
Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072
[No Abstract] [Full Text] [Related]
37. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR
Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
[TBL] [Abstract][Full Text] [Related]
38. A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation.
Macdonald PS; Keogh AM; Marshman D; Richens D; Harvison A; Kaan AM; Spratt PM
J Heart Lung Transplant; 1995; 14(1 Pt 1):32-8. PubMed ID: 7727473
[TBL] [Abstract][Full Text] [Related]
39. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.
Gerbase MW; Dubois D; Rothmeier C; Spiliopoulos A; Wunderli W; Nicod LP
Chest; 1999 Nov; 116(5):1265-72. PubMed ID: 10559085
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
